BlackRock, Inc. 13D and 13G filings for Kura Oncology, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-17 09:35 am Sale |
2025-03-31 | 13G | Kura Oncology, Inc. KURA |
BlackRock Inc. BLK |
6,329,050 7.800% |
-1,605,054 (-20.23%) |
Filing |
| 2025-01-08 7:42 pm Purchase |
2024-12-31 | 13G | Kura Oncology, Inc. KURA |
BlackRock Inc. BLK |
7,934,104 10.200% |
618,457 (+8.45%) |
Filing |
| 2024-01-24 2:27 pm Purchase |
2023-12-31 | 13G | Kura Oncology, Inc. KURA |
BlackRock Inc. BLK |
7,315,647 9.800% |
2,152,811 (+41.70%) |
Filing |
| 2023-01-31 1:58 pm Purchase |
2022-12-31 | 13G | Kura Oncology, Inc. KURA |
BlackRock Inc. BLK |
5,162,836 7.600% |
67,810 (+1.33%) |
Filing |
| 2022-02-02 7:11 pm Purchase |
2021-12-31 | 13G | Kura Oncology, Inc. KURA |
BlackRock Inc. BLK |
5,095,026 7.700% |
163,070 (+3.31%) |
Filing |
| 2021-01-29 5:23 pm Purchase |
2020-12-31 | 13G | Kura Oncology, Inc. KURA |
BlackRock Inc. BLK |
4,931,956 7.600% |
1,938,204 (+64.74%) |
Filing |